Produced by: UNIBAS
Shipping From: Basel - CH
Plasmid contains the entire genome of HIV-1 (NL4-3) with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 protease inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on protease inhibitors with virologic therapy failure.
Product Risk Group:
Information on the related virus
Cloned Product: Yes
Can it be used to produce GMO:
Plasmid contains the entire genome of HIV-1 (NL4-3) with specific mutations in the protease gene, which can confer drug resistance to specific protease inhibitors. Might produce infectious virus after transfection into suitable human cells.
Region encompassed in this Product:
entire HIV-1 genome
No mutation compared to the reference sequence
Nucleic Acid preparation technique:
ion exchange column (Macherey Nagel)
TE Buffer -20C